Stelara Approved to Treat Moderate to Severe Ulcerative Colitis in Europe
News
The European Commission (EC) has approved Stelara (ustekinumab) to treat moderately to severely active ulcerative colitis (UC) in adults who are either not responding to, or are intolerant of, standard ... Read more